Wolfe Research downgrades AbbVie Inc. (ABBV) to Peer Perform from Outperform
AbbVie Inc. (NYSE:ABBV) is one of Best-Performing Pharma Stocks in 2025. AbbVie Inc. (NYSE:ABBV) was downgraded to Peer Perform from Outperform on January 8 by Wolfe Research without a price target. The company said the stock already reflects expectations of outperformance in Skyrizi and Rinvoq, so it is sitting on the sidelines pending greater visibility…